Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

669
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
669
Clinical Trials01:16

Clinical Trials

10.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.1K
Clinical Trials: Overview01:11

Clinical Trials: Overview

4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

140
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
140
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

144
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
144
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

250
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
250

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A curious case of maternal mirror syndrome secondary to fetal urinary ascites.

Journal of neonatal-perinatal medicine·2026
Same author

<i>"Methadone at the pharmacy like Suboxone®?… It would untangle a lot of tangles."</i> Perspectives of North Carolinians with lived experience of opioid use on potential benefits of methadone dispensing at community pharmacies.

Substance use & misuse·2026
Same author

Neovascular age-related macular degeneration patient questions for their eye care providers and preferences for education.

Optometry and vision science : official publication of the American Academy of Optometry·2026
Same author

Availability and Cost of Naloxone Over Time: A Longitudinal Secret Shopper Study in North Carolina Community Pharmacies.

Journal of the American Pharmacists Association : JAPhA·2026
Same author

Expanding Methadone Access Through Community Pharmacies: A Qualitative Study Exploring Opioid Treatment Program Staff Perceptions of Pharmacy-Based Medication Units.

Substance use & addiction journal·2026
Same author

Implementing a behavioural intervention for paediatric type 1 diabetes: Key informant perspectives of multilevel barriers and facilitators.

Diabetic medicine : a journal of the British Diabetic Association·2026
Same journal

Healthcare cost savings through hospital pharmacist-collaborative care in heart failure: A microsimulation study.

Journal of the American Pharmacists Association : JAPhA·2026
Same journal

Assessment of comprehensive medication management incorporating a patient-completed medical and medication history form in community practice.

Journal of the American Pharmacists Association : JAPhA·2026
Same journal

Characterizing how community pharmacy teams engage with social drivers of health (SDOH) during routine workflow: A report from the medication safety research network of Indiana (Rx-SafeNet).

Journal of the American Pharmacists Association : JAPhA·2026
Same journal

Geographic disparities in board-certified ambulatory care pharmacists in Appalachia.

Journal of the American Pharmacists Association : JAPhA·2026
Same journal

Development of consensus criteria for problematic medications in active duty service members.

Journal of the American Pharmacists Association : JAPhA·2026
Same journal

Barriers and facilitators to pharmacy-based methadone dosing and dispensing: Semi-structured interviews with pharmacists.

Journal of the American Pharmacists Association : JAPhA·2026
See all related articles

Related Experiment Video

Updated: Jan 12, 2026

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time
06:05

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time

Published on: February 19, 2021

1.6K

Lessons learned in optimizing recruitment and data collection for a pharmacy-based implementation trial.

Abigail G Shackley, Delesha M Carpenter, Heidi Charton

    Journal of the American Pharmacists Association : Japha
    |November 5, 2025
    PubMed
    Summary
    This summary is machine-generated.

    Implementation trials for COVID-19 vaccine hesitancy counseling faced challenges with pharmacist engagement and data collection. Modifications to study design and data collection methods significantly improved trial success.

    More Related Videos

    Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India
    09:33

    Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India

    Published on: December 23, 2022

    2.6K
    A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
    04:53

    A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

    Published on: September 20, 2019

    11.1K

    Related Experiment Videos

    Last Updated: Jan 12, 2026

    The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time
    06:05

    The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time

    Published on: February 19, 2021

    1.6K
    Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India
    09:33

    Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India

    Published on: December 23, 2022

    2.6K
    A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
    04:53

    A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

    Published on: September 20, 2019

    11.1K

    Area of Science:

    • Implementation science
    • Public health interventions
    • Pharmacy practice

    Background:

    • A National Institutes of Health-funded study in Fall 2023 aimed to enhance COVID-19 vaccine hesitancy counseling in pharmacies.
    • The stepped-wedge trial compared standard implementation with virtual facilitation but encountered significant pharmacist engagement and data collection issues within 6-8 weeks.

    Purpose of the Study:

    • To report formative evaluation findings from the first trial year.
    • To detail strategies developed and implemented in Fall 2024 to overcome identified engagement and data collection barriers.

    Main Methods:

    • A formative evaluation utilized semistructured interviews with pharmacists and a review of coaches' notes.
    • Rapid template analysis and consultation with rural patient and implementation science expert advisory panels informed study modifications.
    • Recommendations for study modifications received funder approval.

    Main Results:

    • Barriers included low vaccine demand, patient refusal of audio-recording for fidelity assessment, difficulties with encounter forms, staffing shortages, and pharmacist reluctance to counsel hesitant patients.
    • These issues threatened the successful completion of the implementation trial.

    Conclusions:

    • Modifications involved adjusting data collection (e.g., standardized patients for fidelity), pharmacy recruitment strategies, and the standard implementation approach (enhanced training and tools).
    • These changes, implemented in the trial's new first year (August 2024 - April 2025), led to substantial improvements in study engagement and data collection.
    • The findings underscore the importance of adaptive strategies and stakeholder collaboration in salvaging implementation trials facing contextual challenges.